| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation
|
Craft, Jeffrey M.
|
|
2004
|
24 |
1 |
p. 115-122
|
artikel
|
| 2 |
Amyloid precursor protein compartmentalization restricts β-amyloid production
|
Gandhi, Swetal
|
|
2004
|
24 |
1 |
p. 137-143
|
artikel
|
| 3 |
Cell cultures from animal models of Alzheimer’s disease as a tool for faster screening and testing of drug efficacy
|
Trinchese, Fabrizio
|
|
2004
|
24 |
1 |
p. 15-21
|
artikel
|
| 4 |
Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer’s-like amyloid β in rabbit brain
|
Sparks, D. Larry
|
|
2004
|
24 |
1 |
p. 97-104
|
artikel
|
| 5 |
Development and evaluation of iodinated tracers targeting amyloid plaques for SPECT imaging
|
Kung, Mei-Ping
|
|
2004
|
24 |
1 |
p. 49-53
|
artikel
|
| 6 |
Development of a PET/SPECT agent for amyloid imaging in Alzheimer’s disease
|
Wang, Yanming
|
|
2004
|
24 |
1 |
p. 55-62
|
artikel
|
| 7 |
Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys
|
Buccafusco, Jerry J.
|
|
2004
|
24 |
1 |
p. 85-91
|
artikel
|
| 8 |
Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo
|
Boules, Mona
|
|
2004
|
24 |
1 |
p. 123-128
|
artikel
|
| 9 |
Drug discovery
|
Smith, Jonathan D.
|
|
2004
|
24 |
1 |
p. 145-147
|
artikel
|
| 10 |
Drug discovery for Alzheimer’s disease
|
Refolo, Lorenzo M.
|
|
2004
|
24 |
1 |
p. 1-8
|
artikel
|
| 11 |
EFRH-phage immunization of Alzheimer’s disease animal model improves behavioral performance in morris water maze trials
|
Lavie, Vered
|
|
2004
|
24 |
1 |
p. 105-113
|
artikel
|
| 12 |
FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein
|
Morse, Lee Jae
|
|
2004
|
24 |
1 |
p. 129-136
|
artikel
|
| 13 |
Mapreg
|
Baulieu, Etienne-Emile
|
|
2004
|
24 |
1 |
p. 63-65
|
artikel
|
| 14 |
NAP mechanisms of neuroprotection
|
Gozes, Illana
|
|
2004
|
24 |
1 |
p. 67-72
|
artikel
|
| 15 |
Neurocognitive aging and cardiovascular fitness
|
Colcombe, Stan J.
|
|
2004
|
24 |
1 |
p. 9-14
|
artikel
|
| 16 |
Novel approaches to models of Alzheimer’s disease pathology for drug screening and development
|
Shaughnessy, Laura
|
|
2004
|
24 |
1 |
p. 23-32
|
artikel
|
| 17 |
Novel glycosaminoglycan precursors as antiamyloid agents
|
Kisilevsky, Robert
|
|
2004
|
24 |
1 |
p. 167-172
|
artikel
|
| 18 |
Progress toward identification of protease activity involved in proteolysis of apolipoprotein E in human brain
|
Marques, Marcos A.
|
|
2004
|
24 |
1 |
p. 73-80
|
artikel
|
| 19 |
Quantitative MRI assessment of Alzheimer’s disease
|
Helpern, Joseph A.
|
|
2004
|
24 |
1 |
p. 45-48
|
artikel
|
| 20 |
Role of acyl-coenzyme A
|
Puglielli, Luigi
|
|
2004
|
24 |
1 |
p. 93-96
|
artikel
|
| 21 |
Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors
|
Zeng, Lei
|
|
2004
|
24 |
1 |
p. 81-84
|
artikel
|
| 22 |
Structure-based functional design of chemical ligands for AMPA-subtype glutamate receptors
|
Zeng, Lei
|
|
|
24 |
1 |
p. 81-84
|
artikel
|
| 23 |
β-synuclein-derived peptides with neuroprotective activity
|
Windisch, Manfred
|
|
2004
|
24 |
1 |
p. 155-165
|
artikel
|
| 24 |
Transforming growth factor-β signaling pathway as a therapeutic target in neurodegeneration
|
Wyss-Coray, Tony
|
|
2004
|
24 |
1 |
p. 149-153
|
artikel
|
| 25 |
Validity of the Mindstreams™ computerized cognitive battery for mild cognitive impairment
|
Dwolatzky, Tzvi
|
|
2004
|
24 |
1 |
p. 33-44
|
artikel
|
Tijdschrift beschrijving